Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biorestorative Therapies Inc (BRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,682
  • Shares Outstanding, K 9,780
  • Annual Sales, $ -8,950 K
  • Annual Income, $ 3,220 K
  • 36-Month Beta 1.22
  • Price/Sales 72.18
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.24
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/18/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5000 +32.00%
on 12/11/18
1.1000 -40.00%
on 11/19/18
-0.3399 (-33.99%)
since 11/13/18
3-Month
0.5000 +32.00%
on 12/11/18
2.9100 -77.32%
on 09/26/18
-0.9000 (-57.69%)
since 09/13/18
52-Week
0.5000 +32.00%
on 12/11/18
4.0000 -83.50%
on 08/02/18
-2.5400 (-79.38%)
since 12/08/17

Most Recent Stories

More News
BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the United States Patent and Trademark...

BRTX : 0.6600 (+13.60%)
BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the appointment of Lance Alstodt as Executive...

BRTX : 0.6600 (+13.60%)
Why This Company is Set for a Major Breakout

HENDERSON, NV / ACCESSWIRE / October 15, 2018 / With the broader market tanking it is likely investors will find safe haven in cannabis and biotech stocks because they are both innovative sectors.

BRTX : 0.6600 (+13.60%)
Cannabis and Biotech Stocks That Are Set to Explode!

HENDERSON, NV / ACCESSWIRE / October 11, 2018 / With the broader market tanking it is likely investors will find safe haven in cannabis and biotech stocks because they are both innovative sectors.

APHQF : 11.5700 (-3.05%)
BRTX : 0.6600 (+13.60%)
VSTM : 4.13 (-5.92%)
TGODF : 2.1700 (-3.98%)
Major Action in Biotech and This is The Next Winner

HENDERSON, NV / ACCESSWIRE / October 5, 2018 / The NASDAQ Biotech Index is up 13% over the past six months. With several large announcements seemingly on the horizon this trend should continue into the...

TRVN : 0.61 (-1.61%)
CLVS : 21.63 (+3.99%)
BRTX : 0.6600 (+13.60%)
PRTK : 6.26 (-4.57%)
BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has entered into a one-year...

BRTX : 0.6600 (+13.60%)
BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced that Wayne J. Olan, M.D. has been appointed...

BRTX : 0.6600 (+13.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade BRTX with:

Key Turning Points

2nd Resistance Point 0.7867
1st Resistance Point 0.7233
Last Price 0.6600
1st Support Level 0.5733
2nd Support Level 0.4867

See More

52-Week High 4.0000
Fibonacci 61.8% 2.6630
Fibonacci 50% 2.2500
Fibonacci 38.2% 1.8370
Last Price 0.6600
52-Week Low 0.5000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar